BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32139796)

  • 21. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.
    Kempster PA; O'Sullivan SS; Holton JL; Revesz T; Lees AJ
    Brain; 2010 Jun; 133(Pt 6):1755-62. PubMed ID: 20371510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson's disease.
    Vo A; Tremblay C; Rahayel S; Shafiei G; Hansen JY; Yau Y; Misic B; Dagher A
    Neuroimage Clin; 2023; 40():103523. PubMed ID: 38016407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
    Lu L; Neff F; Alvarez-Fischer D; Henze C; Xie Y; Oertel WH; Schlegel J; Hartmann A
    Exp Neurol; 2005 Sep; 195(1):27-39. PubMed ID: 15944136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomic profiles in Parkinson's disease.
    Kurvits L; Lättekivi F; Reimann E; Kadastik-Eerme L; Kasterpalu KM; Kõks S; Taba P; Planken A
    Exp Biol Med (Maywood); 2021 Mar; 246(5):584-595. PubMed ID: 33148011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
    Quadri M; Mandemakers W; Grochowska MM; Masius R; Geut H; Fabrizio E; Breedveld GJ; Kuipers D; Minneboo M; Vergouw LJM; Carreras Mascaro A; Yonova-Doing E; Simons E; Zhao T; Di Fonzo AB; Chang HC; Parchi P; Melis M; Correia Guedes L; Criscuolo C; Thomas A; Brouwer RWW; Heijsman D; Ingrassia AMT; Calandra Buonaura G; Rood JP; Capellari S; Rozemuller AJ; Sarchioto M; Fen Chien H; Vanacore N; Olgiati S; Wu-Chou YH; Yeh TH; Boon AJW; Hoogers SE; Ghazvini M; IJpma AS; van IJcken WFJ; Onofrj M; Barone P; Nicholl DJ; Puschmann A; De Mari M; Kievit AJ; Barbosa E; De Michele G; Majoor-Krakauer D; van Swieten JC; de Jong FJ; Ferreira JJ; Cossu G; Lu CS; Meco G; Cortelli P; van de Berg WDJ; Bonifati V;
    Lancet Neurol; 2018 Jul; 17(7):597-608. PubMed ID: 29887161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
    Mezey E; Dehejia AM; Harta G; Tresser N; Suchy SF; Nussbaum RL; Brownstein MJ; Polymeropoulos MH
    Mol Psychiatry; 1998 Nov; 3(6):493-9. PubMed ID: 9857974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease.
    Müller SK; Bender A; Laub C; Högen T; Schlaudraff F; Liss B; Klopstock T; Elstner M
    Neurobiol Aging; 2013 Sep; 34(9):2231-3. PubMed ID: 23566333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.
    Dzamko N; Gysbers AM; Bandopadhyay R; Bolliger MF; Uchino A; Zhao Y; Takao M; Wauters S; van de Berg WD; Takahashi-Fujigasaki J; Nichols RJ; Holton JL; Murayama S; Halliday GM
    Mov Disord; 2017 Mar; 32(3):423-432. PubMed ID: 27911006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease.
    Wakabayashi K; Kakita A; Hayashi S; Okuizumi K; Onodera O; Tanaka H; Ishikawa A; Tsuji S; Takahashi H
    Acta Neuropathol; 1998 May; 95(5):450-4. PubMed ID: 9600590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders.
    Saito Y; Shioya A; Sano T; Sumikura H; Murata M; Murayama S
    Mov Disord; 2016 Jan; 31(1):135-8. PubMed ID: 26748832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiology and pathogenesis of Parkinson's disease.
    Schapira AH; Jenner P
    Mov Disord; 2011 May; 26(6):1049-55. PubMed ID: 21626550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Looking beyond the brain to improve the pathogenic understanding of Parkinson's disease: implications of whole transcriptome profiling of Patients' skin.
    Planken A; Kurvits L; Reimann E; Kadastik-Eerme L; Kingo K; Kõks S; Taba P
    BMC Neurol; 2017 Jan; 17(1):6. PubMed ID: 28068941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson's disease myeloid cells.
    Navarro E; Udine E; de Paiva Lopes K; Parks M; Riboldi G; Schilder BM; Humphrey J; Snijders GJL; Vialle RA; Zhuang M; Sikder T; Argyrou C; Allan A; Chao MJ; Farrell K; Henderson B; Simon S; Raymond D; Elango S; Ortega RA; Shanker V; Swan M; Zhu CW; Ramdhani R; Walker RH; Tse W; Sano M; Pereira AC; Ahfeldt T; Goate AM; Bressman S; Crary JF; de Witte L; Frucht S; Saunders-Pullman R; Raj T
    Nat Aging; 2021 Sep; 1(9):850-863. PubMed ID: 35005630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathology of Lewy body disorders.
    Kövari E; Horvath J; Bouras C
    Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of genetic association studies in people with Lewy body dementia.
    Sanghvi H; Singh R; Morrin H; Rajkumar AP
    Int J Geriatr Psychiatry; 2020 May; 35(5):436-448. PubMed ID: 31898332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
    Gibb WR; Lees AJ
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):745-52. PubMed ID: 2841426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.